Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
Study NCT ID:
NCT00961220
Status:
COMPLETED
Last Update Posted:
2018-05-22
First Post:
2009-08-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-16
First Submit QC Date:
None
Study First Post Date:
2009-08-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-11
Results First Submit QC Date:
None
Results First Post Date:
2015-03-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-23
Last Update Post Date:
2018-05-22
Last Update Post Date Type:
ACTUAL